Business Wire

Tetra Pharm Technologies Prescribes Rootstock ERP to Drive Its Digital Strategy

Share

Danish biopharmaceutical company to utilize Rootstock and Salesforce to enable end-to-end data visibility, improve decision-making, and support growth

Rootstock Software today announced that Tetra Pharm Technologies, a Danish biopharmaceutical company specializing in chronic pain, mental health, and obesity treatments, has selected Rootstock ERP to advance the digital strategy around its manufacturing operations. As a young and rapidly expanding company, Tetra Pharm Technologies is leveraging Rootstock ERP as part of its foundation for growth.

Founded in 2018 by industry veterans Martin Rose and Jesper Breum, Tetra Pharm Technologies is dedicated to improving quality of life for patients through innovative science. With a strong focus on treatments targeting the central nervous system (CNS) and the immune system to treat neurological diseases and psychiatric disorders, the company has grown steadily since its inception. In 2020, Tetra Pharm Technologies opened its first production site in Hillerød and received authorization from the Danish Medicines Agency.

“We saw the importance of putting the right ERP system in place early, before any of our processes became set in stone,” said Steen Jakobsen, Chief Financial Officer of Tetra Pharm Technologies. “We are growing quickly and need tools that will allow us to scale efficiently. After a thorough review of ERP options, we found that Rootstock ERP on the Salesforce Platform offered the best fit with our innovative culture and business needs. Rootstock’s flexibility and seamless integration with Salesforce Sales Cloud will enable us to automate processes and ensure we’re positioned to meet the regulatory requirements of our upcoming clinical trials and potential market expansions.”

“Tetra Pharm Technologies needed a robust ERP solution to provide traceability, help control inventory, and manage costs effectively,” said Nicolai Lyster, Supply Chain Manager at Tetra Pharm Technologies. “Rootstock’s QuickStart Implementation gives us the flexibility to control the pace and depth of our deployment without heavily relying on consultants—a model we haven’t seen with other ERP providers. The Rootstock Success Community has also been a great resource, offering accessible training and support. As we scale, we’re excited about Rootstock’s ability to evolve with our company, offering opportunities to extend our capabilities.”

Tetra Pharm Technologies is leveraging Rootstock’s Learning Center and QuickStart Implementation to support user adoption and a rapid go-live. Using the Rootstock Configuration Wizard, the company is focusing on deploying core financial and operational processes.

“Tetra Pharm Technologies’ decision to implement Rootstock underscores the value of our ERP solution in highly regulated and complex industries like life sciences,” said Rick Berger, CEO of Rootstock Software. “We are excited to work closely with Tetra Pharm Technologies to enhance their manufacturing processes and scale their operations to bring their treatments to market.”

Tetra Pharm Technologies also anticipates that the implementation of Rootstock ERP will significantly reduce its reliance on spreadsheets and manual processes, enabling more accurate reporting, better real-time visibility, and improved decisions in its business.

For more information on how Rootstock ERP helps companies to streamline their manufacturing operations and support growth, schedule a demo today or meet the company at one of its upcoming events.

Salesforce, Sales Cloud, AppExchange, and others are among the trademarks of Salesforce, Inc.

About Rootstock

Rootstock Software provides the leading ERP for product companies, empowering manufacturers, wholesalers, and distributors to turbocharge their operations. Natively built on the Salesforce Platform, Rootstock is a modern, future-proof ERP with a fresh user experience. Customers appreciate Rootstock’s focus on their success—providing AI-ready decisioning capabilities but with a human-first approach. IT teams value Rootstock’s platform as it minimizes the need to coordinate complex customizations and third-party integrations. All of this adds up to delighted customers. As Rootstock continues to grow, stay tuned to hear about its new customers, career opportunities, and LinkedIn posts.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241114198426/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LambdaTest Integrates with Assembla to Streamline Bug Tracking for Development Teams3.6.2025 17:00:00 CEST | Press release

This Integration enables teams with seamless bug tracking capabilities directly from the testing environment, enhancing collaboration and accelerating software delivery cycles. LambdaTest, a unified agentic AI and cloud engineering platform, has announced its partnership with Assembla, a robust cloud-based platform for version control and project management. This collaboration enables software development teams to streamline their bug tracking processes and improve overall productivity. LambdaTest offers developers an exhaustive list of cloud-based testing solutions, including cross-browser compatibility testing, Web and App automation testing, and Real Device testing. Assembla users can now easily integrate with the LambdaTest platform to seamlessly mark bugs with detailed screenshots and assign them to team members. "This integration between LambdaTest and Assembla allows development teams to optimize their testing and bug tracking processes," said Mayank Bhola, Co-Founder and Head o

The Future of AI in the AEC Industry Unveiled at BST Global’s 2025 AI Summit3.6.2025 16:41:00 CEST | Press release

BST Global, the leading provider of AI-powered project intelligence™ solutions for the AEC industry, hosted its second annual AI Summit, May 6–8, 2025, in Palm Beach, FL. The premier event brought together 12 thought leaders from some of the world’s most influential firms, including Arcadis, Arup, AtkinsRéalis, Gensler, GHD, Jacobs, Mott MacDonald, NVIDIA, Parsons, Stantec, and WSP to share insights on how AI is reshaping the future of the AEC industry. Attendees as well as the broader AEC community praised the 2025 AI Summit for its timely content and line-up of industry trailblazers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603538561/en/ BST Global Chief Executive Officer Javier A. Baldor officially kicks off the AI Summit’s first full day of sessions by presenting his perspective on the driving forces impacting the AEC industry and the world at large. He shares three key ways AI and big data will transform nearly

Incyte Announces Multiple Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted for Presentation at EHA 20253.6.2025 16:30:00 CEST | Press release

Late-breaking oral presentation will highlight new data from a trial of INCA033989, an anti-mutant calreticulin (mutCALR)-directed monoclonal antibody, in patients with essential thrombocythemia (ET)Incyte to host an in-person analyst and investor event highlighting the mutCALR data at EHA on Sunday, June 15, 2025, from 6:00 - 7:30 a.m. EDT (12:00 - 1:30 p.m. CEST) Incyte (Nasdaq:INCY) today announced that data from numerous programs in its hematology/oncology portfolio will be presented at the 2025 European Hematology Association (EHA) congress, held June 12 – 15, 2025, in Milan. "We're looking forward to presenting new data from across our hematology/oncology portfolio at the 2025 EHA Congress, including late-breaking data for our first in class, mutCALR-directed monoclonal antibody, INCA033989,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “We believe the data that will be presented at the late-breaking session demonstrate the impact of the no

European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD3.6.2025 16:12:00 CEST | Press release

- Approval Based on Positive Results from the Phase 3 HD21 Trial for StageIIb with Risk Factors/III/IV Hodgkin Lymphoma - ADCETRIS-based Combination Demonstrated Superior Safety Profile and Efficacy Compared to eBEACOPP, a Standard of Care Regimen in Europe - Second Approval in Frontline Hodgkin Lymphoma Broadens ADCETRIS’ Therapeutic Reach, Adding to Six Previously Approved, Distinct Indications for ADCETRIS in the European Union Takeda(TSE:4502/NYSE:TAK) today announced that the European Commission (EC) approved ADCETRIS® (brentuximab vedotin) in combination with etoposide, cyclophosphamide, doxorubicin, dacarbazine and dexamethasone (ECADD) – a chemotherapy regimen – in adult patients with newly diagnosed Stage IIb with risk factors/III/IV Hodgkin lymphoma. The decision follows a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) on April 25, 2025. The approval for this ADCETRIS-based combination regimen, known as BrECADD, in frontline Hodgkin lymphoma i

Automotive Industry Shifts Gears As Talent and Technology Take Center Stage3.6.2025 16:00:00 CEST | Press release

Rockwell Automation report shows manufacturers are leaning into AI, upskilling and innovation to overcome workforce and operational challenges Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced the results of the 10th annual “State of Smart Manufacturing Report: Automotive Edition.” The global study encompasses the responses of 130 leaders across automotive and tire manufacturers, original equipment manufacturers, engineering procurement companies and systems integrators across 15 countries, revealing a sector rapidly embracing change to stay competitive. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603797393/en/ Rockwell Automation report shows manufacturers are leaning into AI, upskilling and innovation to overcome workforce and operational challenges. Workforce pressures have emerged as the most urgent challenge for automot

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye